Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

Optimizing clinico-genomic disease prediction across ancestries: a machine learning strategy with Pareto improvement

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Predictive analytics with gradient boosting in clinical medicine

Optimised stacked machine learning algorithms for genomics and genetics disorder detection in the healthcare industry

A Non-Parametric Method for Building Predictive Genetic Tests on High-Dimensional Data

Machine Learning Strategies for Improved Phenotype Prediction in Underrepresented Populations

Improving genetic risk prediction across diverse population by disentangling ancestry representations

Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank

Prediction of disease-free survival for precision medicine using cooperative learning on multi-omic data

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Improving genetic risk modeling of dementia from real-world data in underrepresented populations

Genetic risk prediction in complex disease

Improving genetic risk prediction by leveraging pleiotropy

Multiclass Disease Predictions Based on Integrated Clinical and Genomics Datasets

A Probabilistic Model to Predict Clinical Phenotypic Traits from Genome Sequencing

Characterizing diseases using genetic and clinical variables: A data analytics approach

A Machine Learning Model for Disease Risk Prediction by Integrating Genetic and Non-Genetic Factors

Subpopulation-specific machine learning prognosis for underrepresented patients with double prioritized bias correction

Big genomics and clinical data analytics strategies for precision cancer prognosis

Machine learning model to predict risk assessment of a child inheriting a genetic disorder

Integrative machine learning approaches for predicting disease risk using multi-omics data from the UK Biobank